Search tips
Search criteria 


Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. 1982 February; 41(1): 59–65.
PMCID: PMC1000865

Allopurinol treatment and its effect on renal function in gout: a controlled study.


Fifty-nine patients with primary gout were treated with either a combination of colchicine and allopurinol or colchicine alone. Assessments of renal function over 2 years revealed a statistically significant fall of glomerular filtration rate an urine concentrating ability in those receiving only colchicine. The renal function of patients given allopurinol did not change. Treatment with allopurinol resulted ina significant reduction of ammonium excretion, a phenomenon which could not be readily explained. Urate clearance also declined during allopurinol treatment, and the impaired urate clearance associated with gout became more evident. The most important observation was that allopurinol retarded an apparent decline of renal function. Presumably this was achieved through its hypouricaemic effect and implies that the hyperuricaemia of gouty patients is deleterious to the kidneys.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (966K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Klinenberg JR. Hyperuricemia and gout. Med Clin North Am. 1977 Mar;61(2):299–312. [PubMed]
  • Steele TH. Asymptomatic hyperuricemia: pathogenic or innocent bystander? Arch Intern Med. 1979 Jan;139(1):24–25. [PubMed]
  • Fessel WJ. Renal outcomes of gout and hyperuricemia. Am J Med. 1979 Jul;67(1):74–82. [PubMed]
  • Yü TF, Berger L, Dorph DJ, Smith H. Renal function in gout. V. Factors influencing the renal hemodynamics. Am J Med. 1979 Nov;67(5):766–771. [PubMed]
  • Gibson T, Highton J, Potter C, Simmonds HA. Renal impairment and gout. Ann Rheum Dis. 1980 Oct;39(5):417–423. [PMC free article] [PubMed]
  • Weinman EJ. Uric acid and the kidney. Perspect Nephrol Hypertens. 1976;3:141–158. [PubMed]
  • Rosenfeld JB. Effect of long-term allopurinol administration on serial GFR in normotensive and hypertensive hyperuricemic subjects. Adv Exp Med Biol. 1974;41:581–596. [PubMed]
  • Briney WG, Ogden D, Bartholomew B, Smyth CJ. The influence of allopurinol on renal function in gout. Arthritis Rheum. 1975 Nov-Dec;18(6 Suppl):877–881. [PubMed]
  • Scott JT. Long-term management of gout and hyperuricaemia. Br Med J. 1980 Nov 1;281(6249):1164–1166. [PMC free article] [PubMed]
  • Garnett ES, Parsons V, Veall N. Measurement of glomerular filtration-rate in man using a 51Cr-edetic-acid complex. Lancet. 1967 Apr 15;1(7494):818–819. [PubMed]
  • SEARCY RL, BERGQUIST LM. A new color reaction for the quantitation of serum cholesterol. Clin Chim Acta. 1960 Mar;5:192–199. [PubMed]
  • Chan JC. The rapid determination of urinary titratable acid and ammonium and evaluation of freezing as a method of preservation. Clin Biochem. 1972 Jun;5(2):94–98. [PubMed]
  • Gutman AB. The past four decades of progress in the knowledge of gout, with an assessment of the present status. Arthritis Rheum. 1973 Jul-Aug;16(4):431–445. [PubMed]
  • Hollingworth P, Reardon JA, Scott JT. Acute gout during hypouricaemic therapy: prophylaxis with colchicine. Ann Rheum Dis. 1980 Oct;39(5):529–529. [PMC free article] [PubMed]
  • Gibson T, Kilbourn K, Horner I, Simmonds HA. Mechanism and treatment of hypertriglyceridaemia in gout. Ann Rheum Dis. 1979 Feb;38(1):31–35. [PMC free article] [PubMed]
  • Warren SE, Ebert E, Swerdlin AH, Steinberg SM, Stone R. Clonidine and propranolol paradoxical hypertension. Arch Intern Med. 1979 Feb;139(2):253–253. [PubMed]
  • Grahame R, Scott JT. Clinical survey of 354 patients with gout. Ann Rheum Dis. 1970 Sep;29(5):461–468. [PMC free article] [PubMed]
  • Cameron JS. Uric acid and the kidney. Proc R Soc Med. 1973 Sep;66(9):900–902. [PubMed]
  • BROWN J, MALLORY GK. Renal changes in gout. N Engl J Med. 1950 Aug 31;243(9):325–329. [PubMed]
  • SOKOLOFF L. The pathology of gout. Metabolism. 1957 May;6(3):230–243. [PubMed]
  • GONICK HC, RUBINI ME, GLEASON IO, SOMMERS SC. THE RENAL LESION IN GOUT. Ann Intern Med. 1965 Apr;62:667–674. [PubMed]
  • Barlow KA, Beilin LJ. Renal disease in primary gout. Q J Med. 1968 Jan;37(145):79–96. [PubMed]
  • Klinenberg JR, Kippen I, Bluestone R. Hyperuricemic nephropathy: pathologic features and factors influencing urate deposition. Nephron. 1975;14(1):88–98. [PubMed]
  • Emmerson BT. Gout, uric acid and renal disease. Med J Aust. 1976 Mar 20;1(12):403–405. [PubMed]
  • Plante GE, Durivage J, Lemieux G. Renal excretion of hydrogen in primarygout. Metabolism. 1968 Apr;17(4):377–385. [PubMed]
  • Vogler WR, Drane JW. Effect of allopurinol on urinary ammonia excretion in patients with gout. Metabolism. 1969 Jun;18(6):519–544. [PubMed]
  • Steele TH, Rieselbach RE. The renal mechanism for urate homeostasis in normal man. Am J Med. 1967 Dec;43(6):868–875. [PubMed]
  • Gutman AB, Yü TF, Berger L. Renal function in gout. 3. Estimation of tubular secretion and reabsorption of uric acid by use of pyrazinamide (pyrazinoic acid). Am J Med. 1969 Oct;47(4):575–592. [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group